Lymphocyte‐Activation Gene 3 Facilitates Pathological Tau Neuron‐to‐Neuron Transmission
Open Access
- 7 February 2024
- journal article
- research article
- Published by Wiley in Advanced Science
- Vol. 11 (16) , e2303775
Abstract
The spread of prion‐like protein aggregates is a common driver of pathogenesis in various neurodegenerative diseases, including Alzheimer's disease (AD) and related Tauopathies. Tau pathologies exhibit a clear progressive spreading pattern that correlates with disease severity. Clinical observation combined with complementary experimental studies has shown that Tau preformed fibrils (PFF) are prion‐like seeds that propagate pathology by entering cells and templating misfolding and aggregation of endogenous Tau. While several cell surface receptors of Tau are known, they are not specific to the fibrillar form of Tau. Moreover, the underlying cellular mechanisms of Tau PFF spreading remain poorly understood. Here, it is shown that the lymphocyte‐activation gene 3 (Lag3) is a cell surface receptor that binds to PFF but not the monomer of Tau. Deletion of Lag3 or inhibition of Lag3 in primary cortical neurons significantly reduces the internalization of Tau PFF and subsequent Tau propagation and neuron‐to‐neuron transmission. Propagation of Tau pathology and behavioral deficits induced by injection of Tau PFF in the hippocampus and overlying cortex are attenuated in mice lacking Lag3 selectively in neurons. These results identify neuronal Lag3 as a receptor of pathologic Tau in the brain,and for AD and related Tauopathies, a therapeutic target.Keywords
All Related Versions
Funding Information
- AbbVie
- Goizueta Alzheimer's Disease Research Center, Emory University (P50 AG05146)
- Maryland Stem Cell Research Fund (2019‐MSCRFD‐4292)
- Parkinson's Foundation (PF‐JFA‐1933)
- National Institute of Neurological Disorders and Stroke (R21NS125559)
- Alzheimer's Disease Research Center, University of Pittsburgh (P30AG066507)
- Division of Microbiology and Infectious Diseases (R01 AI144422)
- CurePSP (658‐2018‐06)
- National Institute on Aging (K01AG056841)
This publication has 53 references indexed in Scilit:
- Heparan Sulfate Proteoglycans (HSPGs) Serve as the Mediator Between Monomeric Tau and Its Subsequent Intracellular ERK1/2 Pathway ActivationJournal of Molecular Neuroscience, 2022
- The Open Field Test for Measuring Locomotor Activity and Anxiety-Like Behavior2018
- Soluble tau aggregates, not large fibrils, are the toxic species that display seeding and cross‐seeding behaviorProtein Science, 2018
- Extracellular Monomeric and Aggregated Tau Efficiently Enter Human Neurons through Overlapping but Distinct PathwaysCell Reports, 2018
- Production of recombinant tau oligomers in vitro2017
- Differential subcellular localization of the regulatory T‐cell protein LAG‐3 and the coreceptor CD4European Journal of Immunology, 2010
- Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistryActa Neuropathologica, 2006
- Phenotypic analysis of the murine CD4-related glycoprotein, CD223 (LAG-3)European Journal of Immunology, 2002
- Staging of alzheimer's disease-related neurofibrillary changesNeurobiology of Aging, 1995
- Identification and cloning of ELF-1, a developmentally expressed ligand for the Mek4 and Sek receptor tyrosine kinasesCell, 1994